Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply
Resilience and Lilly expand strategic partnership first established in 2023 Investment will significantly increase U.S. production of Lilly’s...
BLOG
Read on
Resilience Announces Relocation of West Coast Headquarters to Ohio and Expansion of Sterile Manufacturing Capabilities
BLUE ASH, Ohio, June 18, 2026 – Resilience, along with Ohio Governor Mike DeWine, JobsOhio, the City of Blue Ash, and REDI Cincinnati, today...
From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era
Published by Drug Development & Delivery Resilience has spent the past year reshaping its business with a clear objective: sharpen focus, strengthen...
.png)
Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
.png)
CDMOs Are Making Their Supply Chains More Resilient & Secure
Published byDrug Development & Delivery Growing R&D activities, personalized medicines, large-scale production of biologics, and access to new...
Starburst Data Rebel Awards: Data Product of the Year
We are proud to announce that Adam Mendez, Head of Data Engineering and Architecture and the Data Platform Team at Resilience, has won the Starburst...
Accelerating Clinical Timelines of Induced Pluripotent Stem Cells (iPSCs) with Pluristyx
Resilience and Pluristyx have entered a strategic collaboration to accelerate and simplify the transition of promising iPSC-derived therapies from...
Opening of Resilience's West Coast Cell Therapy PAD Center
Resilience is proud to announce the official opening of our West Coast (San Diego, CA) Cell Therapy PAD center. This location will serve as our...
